1. Home
  2. KZIA vs KRKR Comparison

KZIA vs KRKR Comparison

Compare KZIA & KRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KZIA
  • KRKR
  • Stock Information
  • Founded
  • KZIA 1994
  • KRKR 2010
  • Country
  • KZIA Australia
  • KRKR China
  • Employees
  • KZIA N/A
  • KRKR N/A
  • Industry
  • KZIA Biotechnology: Pharmaceutical Preparations
  • KRKR Business Services
  • Sector
  • KZIA Health Care
  • KRKR Consumer Discretionary
  • Exchange
  • KZIA Nasdaq
  • KRKR Nasdaq
  • Market Cap
  • KZIA 6.0M
  • KRKR 10.4M
  • IPO Year
  • KZIA 1999
  • KRKR 2019
  • Fundamental
  • Price
  • KZIA $0.89
  • KRKR $3.53
  • Analyst Decision
  • KZIA Strong Buy
  • KRKR
  • Analyst Count
  • KZIA 2
  • KRKR 0
  • Target Price
  • KZIA $11.50
  • KRKR N/A
  • AVG Volume (30 Days)
  • KZIA 5.5M
  • KRKR 1.3M
  • Earning Date
  • KZIA 03-26-2025
  • KRKR 09-03-2024
  • Dividend Yield
  • KZIA N/A
  • KRKR N/A
  • EPS Growth
  • KZIA N/A
  • KRKR N/A
  • EPS
  • KZIA N/A
  • KRKR N/A
  • Revenue
  • KZIA $1,655,324.00
  • KRKR $41,654,350.00
  • Revenue This Year
  • KZIA N/A
  • KRKR $45.99
  • Revenue Next Year
  • KZIA N/A
  • KRKR $31.46
  • P/E Ratio
  • KZIA N/A
  • KRKR N/A
  • Revenue Growth
  • KZIA 248000.00
  • KRKR N/A
  • 52 Week Low
  • KZIA $0.85
  • KRKR $2.76
  • 52 Week High
  • KZIA $15.80
  • KRKR $12.99
  • Technical
  • Relative Strength Index (RSI)
  • KZIA 29.40
  • KRKR 42.46
  • Support Level
  • KZIA $0.87
  • KRKR $4.20
  • Resistance Level
  • KZIA $1.60
  • KRKR $6.20
  • Average True Range (ATR)
  • KZIA 0.21
  • KRKR 1.80
  • MACD
  • KZIA 0.01
  • KRKR -0.23
  • Stochastic Oscillator
  • KZIA 1.69
  • KRKR 3.10

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

About KRKR 36Kr Holdings Inc.

36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.

Share on Social Networks: